1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Skin conditions
  5. Psoriasis

Certolizumab pegol for treating moderate to severe plaque psoriasis

Technology appraisal guidance [TA574] Published: 17 April 2019

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

History

A list of downloadable documents created during development.

Expected publication

  • Equality Impact Assessment (Guidance development) PDF 160 KB 17 April 2019  

Final draft guidance

  • Final draft guidance  
  • Final appraisal document PDF 318 KB 08 March 2019  
  • Committee papers PDF 1.96 MB 08 March 2019  
  • Public committee slides PDF 909 KB 08 March 2019  

Draft guidance

  • Draft guidance  
  • Appraisal consultation document PDF 412 KB 04 December 2018  
  • Committee papers PDF 16.28 MB 04 December 2018  
  • Public committee slides PDF 1.9 MB 04 December 2018  

Invitation to participate

  • Final scope PDF 237 KB 15 June 2018  
  • Final matrix PDF 259 KB 15 June 2018  
  • NICE's response to comments on the draft scope and provisional matrix PDF 720 KB 15 June 2018  
  • Equality impact assessment (Scoping) PDF 78 KB 15 June 2018  

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

  • Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators  
  • Draft scope pre referral PDF 348 KB 28 September 2017  
  • Draft matrix pre referral PDF 256 KB 28 September 2017